Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NICHD

Precision Laser Capture Microdissection Utilizing Short Pulse Length

  • Read more about Precision Laser Capture Microdissection Utilizing Short Pulse Length
US Patent 6,897,038
Filed on 2002-04-08

METHODS OF MAKING, USING AND PHARMACEUTICAL FORMULATIONS COPRISING 7 ALPHA, 11BETA-DIMETHYL-17BETA-HYDROXYLATIONS-4,14 DIEN-3-ONE AND 17...

  • Read more about METHODS OF MAKING, USING AND PHARMACEUTICAL FORMULATIONS COPRISING 7 ALPHA, 11BETA-DIMETHYL-17BETA-HYDROXYLATIONS-4,14 DIEN-3-ONE AND 17...
Patent Cooperation Treaty
PCT/US2002/009886
Filed on 2002-03-29

Human Gene Critical To Fertility

  • Read more about Human Gene Critical To Fertility
Patent Cooperation Treaty
PCT/US2002/009776
Filed on 2002-03-29

Use of Activity-Dependent Neutrophic Factor-Derived Polypeptides for Enhancing Learning And Memory

  • Read more about Use of Activity-Dependent Neutrophic Factor-Derived Polypeptides for Enhancing Learning And Memory
US Patent 7,427,598
Filed on 2002-11-27

USE OF HEPRPESVIRUSES, PROTEINS AND NUCLEIC ACIDS ENCODING THE PROTIENS TO INHIBIT CCR5-TROPIC HIV-1 INFECTION AND REPLICATION

  • Read more about USE OF HEPRPESVIRUSES, PROTEINS AND NUCLEIC ACIDS ENCODING THE PROTIENS TO INHIBIT CCR5-TROPIC HIV-1 INFECTION AND REPLICATION
Patent Cooperation Treaty
PCT/US02/10048
Filed on 2002-03-28

METHODS FOR THE PRODUCTION OF PURIFIED RECOMBINANT HUMAN UTEROGLOBIN FOR THE TREATMENT OF INFLAMMATORY AND FIBROTIC CONDITIONS.

  • Read more about METHODS FOR THE PRODUCTION OF PURIFIED RECOMBINANT HUMAN UTEROGLOBIN FOR THE TREATMENT OF INFLAMMATORY AND FIBROTIC CONDITIONS.
US Patent 7,122,344
Filed on 2001-07-02

Methods For The Production of Purified Recombinant Human Treatment of Impaired Lung function & To Enhance Lyphocyte Production

  • Read more about Methods For The Production of Purified Recombinant Human Treatment of Impaired Lung function & To Enhance Lyphocyte Production
US Application 09/835,784
Filed on 2001-04-13

Methods And Compositions For The Treatment of Fribrotic Conditions & Impaired Lung Function & to Enchance Lyphocyte Production

  • Read more about Methods And Compositions For The Treatment of Fribrotic Conditions & Impaired Lung Function & to Enchance Lyphocyte Production
US Application 09/549,926
Filed on 2001-04-13

Methods And Composititions For Treatment of Fribrotic Conditions & Impaired Lung function & To Enchance Lyphocyte Production

  • Read more about Methods And Composititions For Treatment of Fribrotic Conditions & Impaired Lung function & To Enchance Lyphocyte Production
US Application 09/120,264
Filed on 2000-04-14

ORALLY ACTIVE PEPTIDES THAT PREVENT CELL DAMAGE AND DEATH

  • Read more about ORALLY ACTIVE PEPTIDES THAT PREVENT CELL DAMAGE AND DEATH
US Patent 7,384,908
Filed on 2002-02-12

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 132
  • Page 133
  • Page 134
  • Page 135
  • Page 136
  • Page 137
  • Page 138
  • Page 139
  • Page 140
  • …
  • Next page ››
  • Last page Last »
Subscribe to NICHD
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health